SECsense Logo

InterCure Ltd. 6-K Report: Leadership Change & Financing Update (Feb 2025)

$INCR
Form 6-K
Filed on: 2025-02-13
Source
InterCure Ltd. 6-K Report: Leadership Change & Financing Update (Feb 2025)

Here are the key insights extracted from the financial report section:

  1. Company Name: InterCure Ltd.
  2. Form Type: 6-K (Report of Foreign Private Issuer)
  3. Commission File Number: 001-40614
  4. Report Date: February 12, 2025
  5. Change in Leadership:
  • Chairman of the Board: Mr. Ehud Barak will step down as Chairman effective February 13, 2025.
  • Successor: Mr. Alexander Rabinovich, who has served as CEO for the past five years, will take over the role of Chairman.
  1. Financing Update: The company completed a financing round, which was previously reported in a December 19, 2024, filing.
  2. Attached Exhibit: The press release titled “InterCure Names Alex Rabinovich as Chairman Replacing Ehud Barak” is included as Exhibit 99.1, providing additional context about the leadership change.
  3. Address: The principal executive office is located at 85 Medinat ha-Yehudim Street, Herzliya, 4676670, Israel.

This section indicates a significant leadership transition within InterCure Ltd., which may affect the company's strategic direction moving forward. The completion of financing is also a pivotal update that could impact future operations and growth.